AU4567299A - C-cbl suppression of neoplastic transformation - Google Patents

C-cbl suppression of neoplastic transformation

Info

Publication number
AU4567299A
AU4567299A AU45672/99A AU4567299A AU4567299A AU 4567299 A AU4567299 A AU 4567299A AU 45672/99 A AU45672/99 A AU 45672/99A AU 4567299 A AU4567299 A AU 4567299A AU 4567299 A AU4567299 A AU 4567299A
Authority
AU
Australia
Prior art keywords
cbl
suppression
neoplastic transformation
neoplastic
transformation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45672/99A
Inventor
Alexander Y. Tsygankov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple University of Commonwealth System of Higher Education
Original Assignee
Temple University of Commonwealth System of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple University of Commonwealth System of Higher Education filed Critical Temple University of Commonwealth System of Higher Education
Publication of AU4567299A publication Critical patent/AU4567299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU45672/99A 1998-06-22 1999-06-15 C-cbl suppression of neoplastic transformation Abandoned AU4567299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9019098P 1998-06-22 1998-06-22
US60090190 1998-06-22
PCT/US1999/013448 WO1999067380A1 (en) 1998-06-22 1999-06-15 c-Cbl SUPPRESSION OF NEOPLASTIC TRANSFORMATION

Publications (1)

Publication Number Publication Date
AU4567299A true AU4567299A (en) 2000-01-10

Family

ID=22221702

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45672/99A Abandoned AU4567299A (en) 1998-06-22 1999-06-15 C-cbl suppression of neoplastic transformation

Country Status (2)

Country Link
AU (1) AU4567299A (en)
WO (1) WO1999067380A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100204299A1 (en) 2009-02-11 2010-08-12 Daniel Regnier C-cbl and antagonists thereof for the treatment and diagnosis of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667981A (en) * 1994-05-13 1997-09-16 Childrens Hospital Of Los Angeles Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein
ZA966663B (en) * 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.

Also Published As

Publication number Publication date
WO1999067380A1 (en) 1999-12-29

Similar Documents

Publication Publication Date Title
AU1430699A (en) Production of propylene
AU4925799A (en) Production of propylene
AU5100599A (en) Egf-genistein for prevention of restenosis
AU1741101A (en) Process of oxidising primary alcohols
AU3180795A (en) Hydrate inhibition
AU3300599A (en) Per-method designation of security requirements
AU1271297A (en) Inhibitor of ceramidase
AU6007699A (en) Showerhead
AU5743200A (en) Protection of communications
AU690879B1 (en) Earphone
AU6402298A (en) Adaptive filter
AUPP635298A0 (en) Plasma antenna
AU1536799A (en) Bishydroxyureas as inhibitors of the 5-lipoxygenase
AU5389798A (en) Adaptive filter
AU6088299A (en) Improved transformation of plastids
AU4288900A (en) Production of polyethylene
AU4267099A (en) Production of polyethylene
AU1389801A (en) Modification of plants
AU5126298A (en) Inhibition of crib-biting
AU4567299A (en) C-cbl suppression of neoplastic transformation
AU4288399A (en) Manufacture of boxes
AU7711800A (en) Novel uses of 2-bromopalmitate
AU5778698A (en) Reduction of restenosis
AUPO832597A0 (en) Wound treatment compositions
AU2619199A (en) Treatment of waxes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase